Orismilast, Orismilast clinical trials

Orismilast for the treatment of moderate to severe ulcerative colitis

This study is looking into a new medicine called Orismilast for people in the UK with moderate to severe ulcerative colitis. It's a Phase II trial, meaning it's still in the earlier stages of testing. Researchers want to see if the medicine can help people feel better by reducing symptoms.